Corient Private Wealth
JBIO

Corient Private Wealth’s Jade Biosciences JBIO Stock Holding History

Corient Private Wealth’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,741
Closed -$101K – 2725
2025
Q3 		$101K Buy
11,741
+1,608
+16% +$13.1K ﹤0.01% 2443
2025
Q2 		$101K Buy
+10,133
New +$345K ﹤0.01% 2329
2025
Q1 		– Sell
-1,054
Closed -$97.8K – 2292
2024
Q4 		$97.8K Buy
+1,054
New +$90.8K ﹤0.01% 2227

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $281M AUM
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Corient Private Wealth's JBIO Position: Q4 2025 in Review

Corient Private Wealth sold out of Jade Biosciences (JBIO) in Q4 2025, closing a stake of 11,741 shares — an estimated $101K sold.

Corient Private Wealth first reported a position in JBIO in Q4 2024 and held it in 3 quarters. The position peaked at $101K in Q3 2025. 105 funds tracked by Wall St. Rank hold JBIO as of Q4 2025.

  • Corient Private Wealth reported no remaining Jade Biosciences position as of Q4 2025 after selling out during the quarter.
  • Corient Private Wealth sold 11,741 Jade Biosciences shares in Q4 2025, an estimated $101K.
  • Corient Private Wealth first reported a position in Jade Biosciences in Q4 2024 and held it in 3 quarters.
  • Corient Private Wealth's Jade Biosciences position peaked at $101K in Q3 2025.
  • 105 funds tracked by Wall St. Rank held Jade Biosciences as of Q4 2025.

Based on Corient Private Wealth's 13F filing for Q4 2025, filed 19 Feb 2026.